Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1

Conditions

Breast Neoplasms 1223Neoplasms 1028Carcinoma, Non-Small-Cell Lung 747Prostatic Neoplasms 693Colorectal Neoplasms 591Lung Neoplasms 576Leukemia, Myeloid, Acute 396Pancreatic Neoplasms 395Neoplasm Metastasis 389Ovarian Neoplasms 369Multiple Myeloma 369Stomach Neoplasms 318Carcinoma, Hepatocellular 303Melanoma 283Brain Neoplasms 281Recurrence 274Squamous Cell Carcinoma of Head and Neck 266Head and Neck Neoplasms 239Glioblastoma 235Endometrial Neoplasms 232Triple Negative Breast Neoplasms 230Lymphoma 223Precursor Cell Lymphoblastic Leukemia-Lymphoma 222Uterine Cervical Neoplasms 221Sarcoma 202Hematologic Neoplasms 202Urinary Bladder Neoplasms 198Esophageal Neoplasms 190Carcinoma, Renal Cell 188Lymphoma, Non-Hodgkin 176

Interventions

BIVV001 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Coagulation Protein Disorders × 1 year × Clear all
NCT06716814 2026-04-20

LIBERTY

Swedish Orphan Biovitrum

Phase 3 Recruiting
104 enrolled
Classical hematologyLymphoid

Blood Coagulation Disorders, Hemophilia A, Lymphoma, Follicular, Coagulation Protein Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡